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Point-of-care measurement of the stress hormone cortisol will greatly facilitate the timely diagnosis and
management of stress-related disorders. We describe an automated salivary cortisol immunosensor,
incorporating centrifugal ﬂuid valves and a disposable disc-chip that allows for truncated reporting of
cortisol levels (<15 min). The performance characteristics of the immunosensor are optimized through
select blocking agents to prevent the non-speciﬁc adsorption of proteins; immunoglobulin G (IgG) poly-
mer for the pad and milk protein for the reservoirs and the ﬂow channels. Incorporated centrifugal ﬂuid
valves allow for rapid and repeat washings to remove impurities from the saliva samples. An optical
reader and laptop computer automate the immunoassay processes and provide easily accessible digital
readouts of salivary cortisol measurements. Linear regression analysis of the calibration curve for the cor-
tisol immunosensor showed 0.92 of coefﬁcient of multiple determination, R2, and 38.7% of coefﬁcient of
variation, CV, for a range of salivary cortisol concentrations between 0.4 and 11.3 ng/mL. The receiver
operating characteristic (ROC) curve analysis of human saliva samples indicate potential utility for dis-
criminating stress disorders and underscore potential application of the biosensor in stress disorders.
The performance of our salivary cortisol immunosensor approaches laboratory based tests and allows
noninvasive, quantitative, and automated analysis of human salivary cortisol levels with reporting times
compatible with point-of-care applications.
 2014 The Authors. Published by Elsevier B.V. This is anopenaccess article under theCCBY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
The intersection of the growing body of knowledge about men-
tal health bioindicators with advances in proteomic technologies
presents great potential in the early detection, diagnosis and man-
agement of a range of stress-related disorders. Of particular inter-
est is the stress hormone cortisol which reﬂects the underlying
neuroendocrine response to stressors and is commonly used as
marker of stress reactivity [7,13]. On exposure to a stressor, the
body’s hypothalamic-pituitary-adrenal (HPA) axis responds by
stimulating the production and secretion of cortisol from the adre-
nal glands. Consequently, cortisol is considered to be a useful mea-
sure of the HPA axis adaptation to stress and disease [12]. Altered
cortisol levels have been linked to a range of stress-related disor-
ders including depression [2], post-traumatic stress disorder [19],irritable bowel syndrome [6] and increased susceptibility to infec-
tions [22].
Although blood is the most commonly used bioﬂuid for bio-
marker detection and measurement, saliva presents a very compel-
ling alternate when it comes to cortisol estimation. For one,
salivary cortisol correlates well with free and biologically-active
cortisol in the blood (correlation coefﬁcient, R = 0.81–0.97,
[25,11]. Furthermore, the levels of the free cortisol in saliva are
independent of transport mechanisms, ﬂow rates or salivary
enzymes [12]. The simple and nonintrusive nature of saliva collec-
tion offers multiple advantages. Unlike blood, saliva collections are
readily acceptable to patients and do not provoke the needle-
induced anxiety or distress that can artiﬁcially alter stress marker
levels. Collections do not require trained healthcare professionals
and can be accomplished by patients in naturalistic settings.
Because saliva is produced continuously and does not clot, it can
be sampled repeatedly at short intervals nor does it require special
collection and processing equipment. All these qualities render sal-
iva the preferred bioﬂuid for assessing cortisol levels as a reﬂection
of the neuroendocrine response to stressors.
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and management of stress-related disorders requires correspond-
ing developments in bioanalytical technologies to enable rapid
analysis and results reporting. Immediate access to a patient’s sal-
ivary cortisol levels would empower clinicians to make timely and
appropriate decisions at the ‘‘point-of-care’’ and enable patient-
centered healthcare. To address the need for near real-time results,
various investigators have advanced a range of bioanalytical plat-
forms and strategies for rapid cortisol analysis; immunosensors
based on piezoelectric elements [5], labeled conjugates [8,16],
ultrasound [9], colloidal gold conjugates [15], gold nanowires
[14], immune-chromatography [28], graphite electrodes [10],
micro-electrodes [4], carbon nanotubes [23], electrochemical
impedance spectroscopy [24], and chemiluminescence [20]. Each
of these approaches is involved and includes multiple sample pro-
cessing steps such as passing the bioﬂuid between reservoirs to
achieve a micro total analysis system (lTAS) such a ‘‘lab-on-a-
chip’’ or using repeated washing processes to remove impurities
(e.g., proteins, other steroid hormones) from the sample so as to
improve sensitivity and eliminate cross-reactivity. Previously, we
had described a microﬂuidic device with a ﬂuid control system
incorporating a valve utilizing direct electro-wetting [17,18,27].
However, the multiple washing processes involved were time con-
suming and the ﬂow speed constraints limited the practical utility
of the system for point-of-care measurement of salivary cortisol
levels. To overcome the limitations, we redesigned the immuno-
sensor platform to integrate centrifugal ﬂuid valves that reduce
the washing cycles required for processing the saliva sample. The
biosensor assembly comprises of a disposable disc-chip incorporat-
ing centrifugal ﬂuid valves and a corresponding portable optical
reader. To begin with, we optimized the performance of the disc-
chip by evaluating the effects of different surface pre-treatments.
Subsequently, we evaluated the performance characteristics of
the optimized immunosensor using saliva samples as well as cor-
tisol standards. Finally, we investigated the utility of the salivary
cortisol immunosensor for discriminating mental health states.B Upper sealing 
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Fig. 1. External view of disc-chip incorporating centrifugal ﬂuid valves for a salivary
cortisol immunosensor.2. Materials and methods
2.1. Chemicals
A monoclonal anti-cortisol antibody (10R-C145A, host: Mouse,
Cosmo Bio Co., Ltd., Japan) was used for the immunoassay. An alka-
line phosphatase-labeled anti-cortisol antibody (ALP-labeled anti-
body) conjugate was synthesized using an alkaline phosphatase
labeling kit (Kit-NH2, Wako Pure Chemical Industries, Ltd., Japan).
Cortisol-3-bovine serum albumin (Coltisol-3-CMO-BSA, Cosmo Bio
Co., Ltd., Japan) was immobilized on a polystyrene pad (MS-92302,
Sumitomo Bakelite Co., Ltd., Japan). A chemiluminescent substrate
(chemiluminescent AP microwell, wavelength: 540 nm, BioFX Lab-
oratories Inc., MD) was used for the ALP, and a phosphate buffer
solution (PBS; pH 7.3, 1 mM, Dulbecco A, Oxoid Ltd., UK) was used
as a washing buffer for a reaction reservoir. A bovine serum albu-
min (BSA; Cas no. 9048-46-8, Wako Pure Chemical Industries, Ltd.,
Japan), a PBS (pH 7.3, 1 mM), and a surfactant (Tween 20, Cas no.
9005-64-5, Sigma–Aldrich Co. LLC., MO) were used to synthesize
a blocking agent, BSA-PBS-T. The BSA-PBS-T, a milk protein
(UK-B80, DS Pharma Biomedical Co., Ltd., Japan), and an IgG poly-
mer (MAB-IgG/Fab(polymer), SQ Poly MAB 33, Roche Diagnostics
GmbH, Germany) were used as blocking agents. Salivary cortisol
levels were measured using a cortisol enzyme-linked immunosor-
bent assay (ELISA) kit (1-3002, monoclonal antibody to cortisol,
450 nm measurement wavelength, Salimetrics LLC, State College,
PA). A cortisol standard solution in the ELISA kit was used to deter-
mine the calibration curve.2.2. Centrifugal immunosensor
The disc-chip with a diameter of 120 mm was fabricated using
an acrylic resin and an incorporated centrifugal ﬂuid valve
provided the ﬂuid control mechanism (Fig. 1). The disposable
disc-chip comprised of the following surface elements: a buffer
reservoir (1455 mm3 volume, 2.5 mm depth), an injection
reservoir (35.6 mm3 volume, 1.5 mm depth), a substrate reservoir
(35.6 mm3 volume, 1.5 mm depth), a reaction reservoir
(32.0 mm3 volume, 1.0 mm depth), and a waste ﬂuid reservoir
(556.9 mm3 volume, 2.5 mm depth), all of which were intercon-
nected by miniature ﬂow channels. The ﬂow channels also func-
tioned as valves, and the disc-chip has two different types,
labeled A and B. A polystyrene pad integrated into the disc-chip
was sealed with a transparent upper sealing layer (P96T01S, poly-
ethylene terephthalate, Stem Co., Japan). The pad with cortisol-3-
BSA was placed in the reaction reservoir. The upper layer contained
an inlet for the buffer as well as an inlet for the sample and conju-
gate. Additionally, there was an inlet for the substrate and an air
hole.
Fig. 2A describes the mode of operation for the centrifugal ﬂuid
valves which control the ﬂow of the bioﬂuid. Fig. 2B shows the
principles of the immunoreaction underlying the molecular recog-
nition of cortisol. The automated analytical process is accom-
plished through the following steps:
i. 10 lL of whole saliva sample and 10 lL of conjugate solu-
tion, including the ALP-labeled antibody conjugate, are
dropped simultaneously into the injection reservoir through
the inlet in the upper layer and allowed to react for 1 min to
initiate the immunoreaction.
ii. Immediately afterwards, the disc-chip rotates at 800 rpm for
8 s to blend the solution and propel it through valve A
(0.6 mm width, 0.8 mm depth, and 3 mm length). This step
ends with the mixed sample transferring from the injection
reservoir to the reaction reservoir.
iii. Once in the reaction reservoir, a competitive reaction takes
place between the cortisol in the saliva sample and the cor-
tisol-3-BSA on the pad for the duration of 1 min.
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Fig. 2. (A) Set of the centrifugal ﬂuid valves and the chemical reaction of the salivary cortisol immunosensor. (B) Immunoreaction principles underlying the molecular
recognition of cortisol.
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transferring the sample from the reaction reservoir through
valve B (0.1 mm width, 0.03 mm depth, and 4 mm length)
into the waste ﬂuid reservoir.
v. Next, a washing buffer of 30 lL PBS is introduced into the
buffer reservoir through the corresponding inlet. The disc-
chip rotates again at 800 rpm for 2 s to force the washing
buffer through valve A. Next, the disc-chip is rotated again
at a higher 4000 rpm for 15 s to force the washing buffer
through valve B. Consequently, any unreacted materials
are removed from the reaction reservoir.
vi. Next, 30 lL of the chemiluminescent substrate is dropped
into the substrate reservoir through the corresponding inlet,
and the disc-chip is rotated once more at 800 rpm for 5 s.
The substrate is hydrolyzed by the ALP immobilized on the
pad and the resultant intensity is measured afterwards using
an optical reader.
The salivary cortisol immunosensor system comprises of the
disposable disc-chip with pad, a portable optical reader equipped
with an ampliﬁer (H8258, wavelength: 185–680 nm, Hamamatsu
Photonics K.K., Japan), a stepping motor with a control unit
(PK525HPMA, 0.36 step angle, Oriental Motor Co., Ltd., Japan),
and a laptop computer (FMVLCE70B, Fujitsu Ltd., Japan, Fig. 3A
and B) that controls the component processes. The assembled unit
is cube-shaped with an edge length of 190 mm. The disposable
disc-chips are easily exchanged by removing a simple ﬁxing screw.
Fig. 3C summarizes the procedure for using the salivary cortisol
immunosensor. Sampling kits consisting of a polypropylene cup
(14  17  40.3 mm3) and a collection swab (sterilized dental cot-
ton, 8 mm diameter  12.5 mm length) are used to collect the sal-
iva samples. Saliva is allowed to collect on the ﬂoor of the mouth
and the collection swab is placed under the tongue and allowed
to saturate for 1 min. A 10 lL of the collected saliva sample is then
transferred with a pipette into the injection reservoir along with
10 lL of conjugate. The analytical process is initiated by touching
the start button on the data acquisition program on the laptop.
Once the automated sample processing and analytic steps are com-
pleted, the intensity of the substrate is measured by the optical
reader and the salivary cortisol level automatically estimated fromthe resultant intensity using a calibration curve input into the lap-
top memory. Finally, the quantiﬁed salivary cortisol level is indi-
cated on the laptop display.2.3. Pre-treatment of disk-chip for the immunosensor
Optimization of the analytical platform was carried out by
experimentally investigating the effects of various surface pre-
treatment methods. First, the disc-chips were washed to remove
the releasing agent used in injection molding of the discs. Next, a
water repellent treatment agent (FS-1060TH-0.5, Fluorotechnolo-
gy, Japan) was applied to the reservoirs and the ﬂow channels
(Fig. 4). Then, the effects of three different blocking agents, BSA-
PBS-T (B), milk protein (M), and IgG polymer (I), were analyzed.
Each was applied to both the pad and the disc-chip. The concentra-
tions of the blocking agents applied to the disc-chip were 20 mg/
mL, 4 mg/mL and 40 lg/mL for B, M and I, respectively. The con-
centrations applied to the pads were 2.5 times those applied to
the disc-chips.
The contact angles of the three blocking agents on the plate
were measured using 1 lL of distilled water on an acrylic resin
made from the same material as the disc-chips. A microscope
(VH-E500, Keyence Co., Japan) and image-analysis software (Image
J, Open source) were used to measure the contact angles. At the
same time, the intensities of the optical reader were measured
for each pre-treatment condition using standard cortisol solutions
with concentrations of 1 and 3 ng/mL.2.4. Calibration curve
The calibration curves for the salivary cortisol immunosensor
were established using cortisol standards as well as native human
saliva. The set of cortisol standards ranged from 1 to 10 ng/mL. The
whole saliva samples were obtained from 10 consenting, healthy
male subjects (mean ± standard deviation (SD): 22.6 ± 1.3 yr) using
collection procedures approved by the Institutional Review Board.
The salivary cortisol levels were measured using cortisol ELISA kits
and a plate reader (ARVO MX; Perkin Elmer Life Science, Boston,
MA) and set of human saliva samples between 0.4 and 11.3 ng/
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immunosensor.
2.5. ROC analysis of salivary cortisol immunosensor
To evaluate the analytical performance of the salivary cortisol
immunosensor, saliva samples were collected in the morning andthe afternoon from 10 male subjects and the samples were divided
into two groups based on psychometric assessment of psychologi-
cal stress (high stress and low stress). Analysis of each group of
samples was repeated three times. In order to verify the immuno-
sensor’s capability to potentially screen for traumatic stress, the
preliminary threshold level of cortisol can be set to 2 ng/mL
(2 ng/mL = 5.52 nmol/l, [3,19,21,26]. ROC curves were generated
to verify the discriminatory power of the salivary cortisol level.
The areas under these curves (AUC) were calculated to provide
an overall summary of the diagnostic accuracy of the salivary cor-
tisol levels with the diagnostic capability classiﬁed into three lev-
els; poor when 0.50 6 AUC < 0.69, good when 0.70 6 AUC < 0.89,
and excellent when 0.90 6 AUC < 1.2.6. Statistical analysis
All the analyses were performed with the Statistical Package for
the Social Sciences (SPSS) version 20.0 (SPSS Inc, Chicago, IL).
Unless otherwise stated, all data are expressed as the mean ± SD.3. Results
3.1. Pre-treatment of disc-chip for the immunosensor
The contact angles of the three blocking agents I, M, and B were
67.7, 55.3, and 26.0, respectively (Table 1). The change in contact
angle of the blocking agents, I, M, and B, from untreated surfaces
were +1.9, 10.5, and 39.8, respectively. The water-repellency
of the blocking agents increased incrementally from IgG polymer,
milk protein, and BSA.
Fig. 5 shows the measured intensity results using the standard
cortisol solutions. The symbols show a combination of blocking
agents for the pad and the disc-chip including the reservoirs and
the ﬂow channels (Type pad-disc). The intensities of Type B-B
(the pad was blocked with BSA and the disc-chip was blocked with
BSA) at concentrations of 1 and 3 ng/mL were 94,732 ± 6,738 and
51,902 ± 3,901 respectively and the absolute difference, DI, was
42,830. The intensities of Type I-B at concentrations of 1 and
3 ng/m were 135,293 ± 26,864 and 84,146 ± 10,601, respectively
and the absolute difference was 51,147. The intensities of Type I-
M concentrations of 1 and 3 ng/mL were 124,179 ± 18,579 and
69,091 ± 6,846, respectively and the absolute difference was
55,089. The difference between the intensities for Type I-M is 1.3
times larger than that for Type B-B.3.2. Calibration curve
Calibration curves for the salivary cortisol immunosensor were
established using a set of cortisol standards ranging between 1 and
10 ng/mL. The intensity saturated 300 s after the chemilumines-
cent substrate was moved to the reaction reservoir, then the mea-
surement time of the intensity was set at 300 s. This saturated
value was set as the measured intensity. The difference in intensity
between 1 and 10 ng/mL for Type I-M was larger than that of Types
B-B and I-B. The absolute values of the detected intensities of Type
I-M were 303,426 ± 35,996, 181,668 ± 22,275, and 86,157 ± 9,847
counts/gate when the concentrations of the standard cortisol solu-
tion were 1, 3, and 10 ng/mL, respectively (Fig. 6A).
The results of a linear regression analysis for Type I-M showed
the R2 value was 0.93; the relationship between the relative inten-
sity, I, and the cortisol concentration, Cort, is given by I = 3.09  105
e0.131Cort (count/gate), and the CV is 12.3%. Thus, the detected
intensity is inversely proportional to the cortisol concentration in
the sample.
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for the salivary cortisol immunosensor showed a similar pattern
(Fig. 6B). The difference in intensity between 0.4 and 11.3 ng/mL
reﬂected that found with the cortisol standards, with Type I-M also
larger than those of Types B-B and I-B. The results of a linear
regression analysis for Type I-M showed the R2 value was 0.92;
the relationship between the intensity, I, and the cortisol
concentration, Cort, is given by I = 3.99  105 e0.280Cort (count/
gate), and the CV is 38.7% over the range 0.4–11.3 ng/mL.3.3. ROC analysis of salivary cortisol immunosensor
Fig. 7 shows the ROC curve for the salivary cortisol immunosen-
sor when the saliva samples from the two groups of subjects. For a
cortisol threshold level of 2 ng/mL, the AUC was 0.89, which man-
ifests a good power for discriminating between subjects with and
without traumatic stress symptoms.
4. Discussion
The technical improvements to the salivary cortisol immuno-
sensor platform and the incorporation of centrifugal ﬂuid valves
eliminate many of the sample preprocessing steps associated with
a previous version of our salivary cortisol immunosensor [27]. The
performance of the disc-chip is optimized by choosing the appro-
priate blocking agents. Our evaluation of the effects of different
surface pre-treatments reveal that IgG polymer for the pad and
the milk protein for the reservoirs (Type I-M) and the ﬂow chan-
nels was the most suitable combination of blocking agents to pre-
vent the non-speciﬁc adsorption of proteins (Table 1 and Fig. 5).
The performance characteristics of the salivary cortisol immu-
nosensor were evaluated using cortisol standard solution mea-
sured by the salivary cortisol ELISA. Comparison of the
calibration curves of the salivary cortisol immunosensor with dif-
ferent combinations of the blocking agents, showed that the results
obtained with Type I-M agent had a high correlation with those
obtained by the commercial ELISA assay (R2 = 0.93) and had a
low CV = 12.3% for the range of cortisol standards used (1–10 ng/
mL, Fig. 6A). Additionally, the dynamic range of the cortisol immu-
nosensor (1–10 ng/mL) was broad enough to cover the range of sal-
ivary cortisol concentrations (1–8 ng/mL) reported by Aardal and
Holm [1] in healthy adults (1 ng/mL = 0.1 lg/dL = 2.76 nmol/L).
Thus, the ﬂow can be controlled just by changing the speed and
number of rotations to determine which centrifugal ﬂuid valve will
open. Using a set of centrifugal ﬂuid valves, valves A and B, enables
the setting of any number of washing times to remove impurities.
This mechanism allows for automated-analyses which makes pos-
sible to shorten the sampling-reporting cycle less than 15 min.
20 M. Yamaguchi et al. / Sensing and Bio-Sensing Research 1 (2014) 15–20Analyzed by means of ROC curves, the salivary cortisol was
shown to have good discriminating power (0.88) in discriminating
of psychological stress (Fig. 7). Thus, our early testing of the sali-
vary cortisol immunosensor using ROC curve analysis of human
saliva samples indicates potential utility for near-real time assess-
ment of stress reactions based on salivary cortisol levels.
5. Conclusions
The analytical performance of our salivary cortisol immunosen-
sor, incorporating centrifugal ﬂuid valves and a disposable disc-
chip, allows for automated-analyses of human salivary cortisol
levels within a shortened timespan (<15 min) compatible with
‘‘point-of-care’’ applications. The performance characteristics of
the salivary cortisol immunosensor are optimized though select
blocking agents to prevent the non-speciﬁc adsorption of proteins;
IgG polymer for the pad and milk protein for the reservoirs and the
ﬂow channels. Incorporated centrifugal ﬂuid valves allow multiple
washings to remove impurities. The optical reader and laptop com-
puter automate the immunoassay processes and provide easily
accessible digital readouts of salivary cortisol measurements. Our
early ROC curve analysis of human saliva samples indicate good
utility for discriminating stress disorders and underscore potential
application for point-of-care measurement of cortisol
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